Ariad Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Ariad Pharmaceuticals Ownership

Who owns Ariad Pharmaceuticals?

Ariad Pharmaceuticals is owned by Takeda Pharmaceutical. It was acquired on January 9, 2017.

Ariad Pharmaceuticals Business Overview

Where is Ariad Pharmaceuticals headquartered?

Ariad Pharmaceuticals is headquartered in Cambridge, Massachusetts.

What is Ariad Pharmaceuticals’ revenue?

Ariad Pharmaceuticals disclosed revenue of 119M USD for 2015 and 105M USD for 2014.

What sector is Ariad Pharmaceuticals in?

Ariad Pharmaceuticals is a life science company.

When was Ariad Pharmaceuticals founded?

Ariad Pharmaceuticals was founded in 1991.

Life Science M&A Summary in 2017

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2017. The largest life science acquisition in 2017 was Actelion - which was acquired by Johnson & Johnson for $30.0B.

Join Mergr to view all 248 acquisitions of life science companies in 2017, including 23 acquisitions by private equity firms, and 225 by strategics.

Ariad Pharmaceuticals, Inc.

26 Landsdowne Street,
Cambridge, Massachusetts 02139
United States,
(617) 494-0400
www.ariad.com

Ariad Pharmaceuticals, Inc. is an oncology company focused on transforming the lives of cancer patients with breakthrough medicines. ARIAD utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # - - - - - - 0
Sell (0.0/yr) # 1 - - - - - 1
vol $140M $140M
  1

Most Recent M&A

Company Date Value Type
Ariad Pharmaceuticals - Iclusig Business 2016-05-09 140M USD Divestiture
Cambridge, Massachusetts
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science - - 1 (100%) 140M (100%)
Total - - 1 $140M

By Geo

State/Country Buy Value Sell Value
United States - - 1 140M
  Massachusetts - - 1 140M
Total - - 1 $140M

Deal Values

sell # Total
$100M to $1B 1 $140M
TOTAL $140M
Largest Ariad Pharmaceuticals - Iclusig Business
$140M (2016-05-09)

M&A Connections

Deals
Divested to
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.